Were all clinically important outcomes considered?

This is very important. Many studies only look at "surrogate endpoints". For example, a study may only examine effects of a drug on cholesterol level without reporting death rates, only to find that a drug that seems to lower cholesterol effectively results in a significant risk of death.

Application to Pollock et al's thyroxine paper

In this study, several different endpoints were considered. Death would obviously be a significant endpoint but one must assume there were no deaths during the study period. The subjective measures of physical and psychological well-being are certainly valid and would be valued by patients.

Previous

EBM Home